Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$301.4 - $428.42 $233,584 - $332,025
-775 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$379.46 - $424.54 $12,142 - $13,585
-32 Reduced 3.97%
775 $324,000
Q4 2021

Jan 19, 2022

SELL
$373.53 - $434.12 $209,550 - $243,541
-561 Reduced 41.01%
807 $338,000
Q3 2021

Oct 05, 2021

BUY
$396.76 - $455.92 $3,174 - $3,647
8 Added 0.59%
1,368 $565,000
Q2 2021

Jul 12, 2021

SELL
$372.36 - $412.07 $112,452 - $124,445
-302 Reduced 18.17%
1,360 $539,000
Q1 2021

Apr 22, 2021

SELL
$357.26 - $392.57 $50,730 - $55,744
-142 Reduced 7.87%
1,662 $638,000
Q4 2020

Jan 25, 2021

BUY
$319.05 - $363.32 $70,829 - $80,657
222 Added 14.03%
1,804 $655,000
Q3 2020

Oct 16, 2020

BUY
$280.08 - $347.78 $124,355 - $154,414
444 Added 39.02%
1,582 $533,000
Q2 2020

Jul 08, 2020

SELL
$270.93 - $320.3 $812 - $960
-3 Reduced 0.26%
1,138 $323,000
Q1 2020

Apr 07, 2020

BUY
$243.44 - $359.98 $105,166 - $155,511
432 Added 60.93%
1,141 $315,000
Q4 2019

Jan 07, 2020

SELL
$281.18 - $322.05 $9,841 - $11,271
-35 Reduced 4.7%
709 $228,000
Q3 2019

Nov 06, 2019

SELL
$294.25 - $341.49 $3,236 - $3,756
-11 Reduced 1.46%
744 $221,000
Q2 2019

Aug 13, 2019

BUY
$279.29 - $336.89 $279 - $336
1 Added 0.13%
755 $254,000
Q1 2019

May 14, 2019

BUY
$246.18 - $297.25 $185,619 - $224,126
754 New
754 $223,000
Q4 2018

Feb 14, 2019

SELL
$232.7 - $281.66 $183,134 - $221,666
-787 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$236.3 - $277.15 $30,955 - $36,306
-131 Reduced 14.27%
787 $218,000
Q2 2018

Aug 13, 2018

SELL
$217.98 - $237.23 $32,479 - $35,347
-149 Reduced 13.96%
918 $216,000
Q1 2018

May 10, 2018

BUY
$218.74 - $251.43 $233,395 - $268,275
1,067 New
1,067 $244,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $5.22B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.